Literature DB >> 24126955

Author reply to comment on "atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms".

Cedric Manlhiot1, Brian W McCrindle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24126955     DOI： 10.1007/s00246-013-0806-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


× No keyword cloud information.
  3 in total

Review 1.  The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review.

Authors:  Christos G Mihos; Maria J Salas; Orlando Santana
Journal:  Cardiol Rev       Date:  2010 Nov-Dec       Impact factor: 2.644

2.  Effects of HMG-CoA reductase inhibitors on continuous post-inflammatory vascular remodeling late after Kawasaki disease.

Authors:  Akiko Hamaoka; Kenji Hamaoka; Tomoyo Yahata; Maiko Fujii; Seiichiro Ozawa; Kentaro Toiyama; Masashi Nishida; Toshiyuki Itoi
Journal:  J Cardiol       Date:  2010-08-03       Impact factor: 3.159

3.  The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.

Authors:  S Blankier; B W McCrindle; S Ito; R S M Yeung
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.